Dual roles for immune metagenes in breast cancer prognosis and therapy prediction

BACKGROUND: Neoadjuvant chemotherapy for breast cancer leads to considerable variability in clinical responses, with only 10 to 20% of cases achieving complete pathologic responses (pCR). Biological and clinical factors that determine the extent of pCR are incompletely understood. Mounting evidence...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Genome Med
Autori principali: Alistar, Angela, Chou, Jeff W, Nagalla, Srikanth, Black, Michael A, D’Agostino, Ralph, Miller, Lance D
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4240891/
https://ncbi.nlm.nih.gov/pubmed/25419236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-014-0080-8
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi